Hippocratic AI Announces New Key Executive Appointments to Further Accelerate Growth

PALO ALTO, Calif.--( BUSINESS WIRE)--Hippocratic AI, a global leader and pioneer of generative AI healthcare agents, today announced several strategic executive appointments as the company continues to scale its platform across providers, payors, and life sciences organizations. The additions strengthen Hippocratic AI’s clinical leadership, operational depth, and go-to-market execution as demand accelerates. The appointments follow Hippocratic AI’s $141 million Series C financing announced in November.

“As Hippocratic AI scales, building a leadership team grounded in clinical credibility, operational rigor, and patient safety is non-negotiable,” said Munjal Shah, CEO of Hippocratic AI. “These leaders bring decades of experience across healthcare, AI, and enterprise execution, and they will play a critical role in helping us continue to scale implementation of generative AI healthcare agents responsibly, at scale, and in service of healthcare abundance.”

New Executive Appointments:

These appointments reinforce Hippocratic AI’s commitment to building safe generative AI healthcare agents that improve access and health outcomes as the company continues to scale.

About Hippocratic AI

Hippocratic AI has developed the safest generative AI Agents for healthcare. The company believes that generative AI has the ability to bring healthcare abundance to every person in the world. The company focuses on building non-diagnostic patient-facing clinical AI agents and does not allow its agents to be used to prescribe or diagnose. Hippocratic AI has received a total of $404 million in funding and is backed by leading investors, including Andreessen Horowitz, General Catalyst, Kleiner Perkins, Avenir, NVIDIA’s NVentures, Premji Invest, SV Angel, Google’s CapitalG, and numerous health systems. Learn more at https://hippocraticai.com/.